Annals of Epidemiology
Volume 16, Issue 2 , Pages 85-90 , February 2006

Cardiovascular Risk Among Men Seeking Help for Erectile Dysfunction

Received 3 December 2004 ,Accepted 20 June 2005.

References 

  1. Meuleman EJH, Donkers LHC, Robertson C, Keech M, Boyle P, Kiemeney LALM. Erectiestoornis: Prevalentie en invloed op de kwaliteit van leven; het Boxmeer-onderzoek. Ned Tijdschr Geneeskd. 2001;145:576–581
  2. Krane RJ, Goldstein I, Saenz de Tejada I. Impotence. N Engl J Med. 1989;321:1648–1659
  3. Goldstein I, Lue TF, Padma–Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338:1397–1404
  4. Arora RR, Timoney M, Melili L. Acute myocardial infarction after the use of sildenafil. N Engl J Med. 1999;341:700
  5. Cheitlin MD, Hutter AM, Brindis RG, et al. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. Circulation. 1999;99:168–177
  6. Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB. Erectile dysfunction and coronary risk factors: Prospective results from the Massachusetts Male Aging Study. Prev Med. 2000;30:328–338
  7. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts Male Aging Study. J Urol. 2000;163:460–463
  8. Kirby M, Jackson G, Betteridge J, Friedli K. Is erectile dysfunction a marker for cardiovascular disease?. Int J Clin Pract. 2001;55:614–618
  9. Cheitlin MD. Erectile dysfunction: The earliest sign of generalized vascular disease?. J Am Coll Cardiol. 2004;43:185–186
  10. Van der Lei J, Duisterhout JS, Westerhof JP, Van der Does E, Cromme PVM, Boon WM. The introduction of computer-based patient records in the Netherlands. Ann Intern Med. 1993;119:1036–1041
  11. Strauss SMJM, Bleumink GS, Dieleman JP, Van der Lei J, Stricker BHCh, Sturkenboom MCJM. The incidence of sudden cardiac death in the general population. J Clin Epidemiol. 2004;57:98–102
  12. Breslow NE, Day NE. Statistical methods in cancer research. II.: The Design and Analysis of Cohort Studies. Lyon: International Agency for Research on Cancer; 1987;
  13. Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall; 1991;
  14. McCullagh P, Nelder JA. Generalized Linear Models. London: Chapman & Hall; 1989;
  15. Montorsi P, Montorsi F, Schulman CC. Is erectile dysfunction the “tip of the iceberg” of a systemic vascular disorder?. Eur. Urol. 2003;44:352–354
  16. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol. 1994;151:54–61
  17. Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J. Endothelial function and dysfunction. Part II.: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23:233–246
  18. Speel TWG, van Langen H, Meuleman EJH. The risk of coronary heart disease in men with erectile dysfunction. Eur Urol. 2003;44:366–370
  19. Stroberg P, Frick E, Hedelin H. Is erectile dysfunction really a clinically useful predictor of cardiovascular disease?. Scand J Urol Nephrol. 2005;39:62–65

 This study was supported by an unrestricted grant from Pfizer International, New York.

PII: S1047-2797(05)00241-3

doi: 10.1016/j.annepidem.2005.06.047

Annals of Epidemiology
Volume 16, Issue 2 , Pages 85-90 , February 2006

Article Tools

* Image Usage & Resolution